For World TB Day, TB Advocates Demand Universal Access to Shorter, Safer TB Regimens
Statement / Press • 2023On March 24, World Tuberculosis (TB) Day offers an opportunity to take stock of global progress against the deadliest disease in human history. This year, we face a sobering reality: since the start of the COVID-19 pandemic, rates of TB infection and death are higher than they’ve been since the early 2000s, setting back an already woefully inadequate effort to end the disease.
TAG Applauds Price Reduction of Molbio’s Truenat Diagnostics for Tuberculosis
Statement / Press • 2023Treatment Action Group (TAG) applauds Molbio’s agreement with the Stop TB Partnership, USAID, and the Global Fund to reduce the price of Truenat diagnostic tests for tuberculosis (TB) from US$9 per test to $7.90 per test and to provide quality service and maintenance of Truenat testing instruments globally.
TB Vaccine Development: The Next Chapter Starts Now
Webinars • 2023On Thursday, April 13, Treatment Action Group (TAG) presented this webinar about important developments in TB vaccine research.
Community Call to Action on Equitable Access to Long-Acting Therapies
Statement / Press • 2023The growing pipeline for long-acting therapies and their potential to accelerate various national and global disease elimination goals warrants global community mobilization to ensure equitable access to these therapies.
1 / 4 / 6 x 24 Campaign Launched to Rally Energy, Political Will, Funding Needed to Fight Tuberculosis
Statement / Press • 2022Against the backdrop of the COVID-19 pandemic and other concurrent global health, economic, social, and political crises, the 1 / 4 / 6 x 24 Campaign, launched during the AIDS conference in Montreal, seeks to improve TB treatment and prevention worldwide based on the latest medical innovations and to reignite the fight to end tuberculosis (TB).
Introducing 1/4/6×24: A Campaign That Draws Inspiration from the Past to Change the Trajectory of the Future Fight to End Tuberculosis
TAGline • 2022By Lindsay McKenna, Mike Frick, and Mark Harrington At the 24th International AIDS Conference in Montreal this summer, TAG, Partners In Health (PIH), and Médecins Sans Frontières (MSF) launched the 1/4/6×24 Campaign to accelerate equitable global uptake of newly discovered safer, shorter regimens to cure all forms of tuberculosis (TB). The “1,” “4,” and “6”…
TB CAB 10-Year Anniversary Evaluation Report 2011–2021 and Podcast
Publication • 2022In 2021, the Global Tuberculosis Community Advisory Board (TB CAB) celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.
Community Representation in HIV Research: From Study Volunteers to Investigators
TAGline • 2022By Cheriko A. Boone, Abraham Johnson, and Richard Jefferys In a 1989 article by Dr. Anthony Fauci, “AIDS — Challenges to Basic and Clinical Biomedical Research” — which preceded Treatment Action Group’s founding by just a few years — he described NIH/NIAID’s work on establishing the Community Programs for Clinical Research on AIDS, and he…
Towards Pandemic Equity: Lessons from 30 Years of Syndemic Activism
TAGline • 2022By Mike Frick and Mark Harrington The articles in this 30th anniversary issue of TAGline grapple with “pandemic equity,” an increasingly common catchphrase in global health. COVID-19 has shown that “equity,” like its cousins “justice,” “fairness,” and “equality,” is one of those words whose use rises in proportion to its absence in practice. If it…
Ten Principles for Access to Multi-disease Molecular Diagnostics: A Global Call to Action
Statement / Press • 2022Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) Access Campaign are pleased to launch the Principles for Access to Multi-disease Molecular Diagnostics.